Day-to-day and within-day biological variation of cell-free DNA AT Madsen, JA Hojbjerg, BS Sorensen, A Winther-Larsen EBioMedicine 49, 284-290, 2019 | 58 | 2019 |
MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells KR Jakobsen, C Demuth, AT Madsen, D Hussmann, J Vad-Nielsen, ... Oncogenesis 6 (4), e307-e307, 2017 | 57 | 2017 |
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients A Winther-Larsen, C Demuth, J Fledelius, AT Madsen, K Hjorthaug, ... British journal of cancer 117 (5), 704-709, 2017 | 49 | 2017 |
The anionic biosurfactant rhamnolipid does not denature industrial enzymes JK Madsen, R Pihl, AH Møller, AT Madsen, DE Otzen, KK Andersen Frontiers in microbiology 6, 292, 2015 | 49 | 2015 |
Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment C Demuth, MN Andersen, KR Jakobsen, AT Madsen, BS Sørensen Oncotarget 8 (40), 68221, 2017 | 36 | 2017 |
Biological variation of serum neurofilament light chain CVB Hviid, AT Madsen, A Winther-Larsen Clinical Chemistry and Laboratory Medicine (CCLM) 60 (4), 569-575, 2022 | 34 | 2022 |
IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells. D Hussmann, AT Madsen, KR Jakobsen, Y Luo, BS Sorensen, AL Nielsen Oncotarget 8 (20), 33300, 2017 | 28 | 2017 |
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients AT Madsen, A Winther-Larsen, T McCulloch, P Meldgaard, BS Sorensen Cancers 12 (4), 947, 2020 | 26 | 2020 |
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies MC Pulanco, AT Madsen, A Tanwar, DT Corrigan, X Zang Cellular & Molecular Immunology, 1-20, 2023 | 24 | 2023 |
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors JG Pedersen, AT Madsen, KR Gammelgaard, N Aggerholm-Pedersen, ... Cancers 12 (6), 1414, 2020 | 24 | 2020 |
A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations C Demuth, A Winther-Larsen, AT Madsen, P Meldgaard, BS Sorensen Oncotarget 9 (57), 31066, 2018 | 19 | 2018 |
The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment C Demuth, AT Madsen, B Weber, L Wu, P Meldgaard, BS Sorensen BMC cancer 18 (1), 1-5, 2018 | 18 | 2018 |
Intra‐individual variation of circulating tumour DNA in lung cancer patients JA Hojbjerg, AT Madsen, HH Schmidt, SF Sorensen, M Stougaard, ... Molecular Oncology 13 (10), 2098-2106, 2019 | 16 | 2019 |
Functional contribution and clinical implication of cancer-associated fibroblasts in glioblastoma PM Galbo Jr, AT Madsen, Y Liu, M Peng, Y Wei, MJ Ciesielski, ... Clinical Cancer Research 30 (4), 865-876, 2024 | 9 | 2024 |
Day-to-day and within-day biological variation of cell-free DNA. EBioMedicine 2019; 49: 284–90 AT Madsen, JA Hojbjerg, BS Sorensen, A Winther-Larsen Author and article information From the Division of Maternal-Fetal Medicine …, 0 | 8 | |
Short-term biological variation of serum glial fibrillary acidic protein SH Christensen, CVB Hviid, AT Madsen, T Parkner, A Winther-Larsen Clinical Chemistry and Laboratory Medicine (CCLM) 60 (11), 1813-1819, 2022 | 6 | 2022 |
Functional Contribution of Cancer-Associated Fibroblasts in Glioblastoma PM Galbo Jr, Y Liu, M Peng, Y Wei, AT Madsen, S Graff, C Montagna, ... bioRxiv, 2022.04. 07.487495, 2022 | 4 | 2022 |
Short-term biological variation of serum tryptase AT Madsen, HP Kristiansen, A Winther-Larsen Clinical Chemistry and Laboratory Medicine (CCLM) 62 (4), 713-719, 2024 | 3 | 2024 |
P69. 03 Targeting the STAT3/PIM Kinase Pathway to Overcome EMT-Mediated Acquired Resistance to EGFR TKIs in NSCLC M Clement, AT Madsen, S Finn, S Cuffe, B Sorensen, K Gately Journal of Thoracic Oncology 16 (3), S561-S562, 2021 | 1 | 2021 |
P2. 03-19 Co-Targeting PIM Kinase to Overcome MET Amplified Resistance to EGFR TKIs in NSCLC AT Madsen, G Moore, N Simon, A Mahon, S Cuffe, S Finn, M O'Neill, ... Journal of Thoracic Oncology 14 (10), S690, 2019 | 1 | 2019 |